The role of this transversal study is to assess the specificity and sensitivity of liquid biopsy to detect circulating cells tumor of adenocarcinoma of the ethmoid. Blood sample of participants will be collected at the moment of the surgical procedure or recurrence diagnosis; immediately after surgery; at day 8-10; at month 2-3 of postoperative follow-up. Two comparison groups will be studied: one age and gender-matched group and one professional exposure-matched group to assess the sensitivity and specificity of liquid biopsy
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
42
For cases: 60 mL blood sample (40 ml for CellSave analysis and 20ml for collection) at visit1 then 20 ml for CellSave analysis at visit2 and visit3 For controls: 40 ml (20ml for CellSave analysis and 20ml for collection) at visit1
Number of circulating tumor cell
Presence of at least 1 circulating tumor cell in the liquid biopsies
Time frame: Day0, Day 7 to 10, VMonth 3 for patients ; Day 0 for controls
Number of postoperative circulating tumor cell release
Change of number circulating tumor cells detection in the liquid biopsy after surgery
Time frame: At the surgery
Tumor Node Metastasis (TNM) classification
Description of TNM classification
Time frame: Day 0
Tumor diagnosis
Primary diagnosis or tumor recurrence
Time frame: Day 0
Histological subtype
Description of histological subtype
Time frame: Day 0
Presence of Circulating Tumor Cells (CTCs) in at least one of the patient's peripheral samples
Presence of CTCs in at least one of the patient's peripheral samples
Time frame: at the surgery, day7, month3
Estimated tumour volume
Estimated tumour volume by imaging
Time frame: Day 0
Location of tumour site
Location of tumour site (clinical, during surgery) to be plotted on a diagram
Time frame: Day 0
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.